Compare Pfizer Inc (PFE) vs ABRDN Physical Gold Shares ETF (SGOL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Pfizer Inc vs ABRDN Physical Gold Shares ETF — how do they compare? Pfizer Inc trades at $24.91 (market cap $142.14B), while ABRDN Physical Gold Shares ETF trades at $39.1. The key difference: Pfizer Inc pays a 6.9% dividend while ABRDN Physical Gold Shares ETF pays none. Which is the better fit depends on your goals.
| PFE | SGOL | |
|---|---|---|
Market Cap | $142.14B | — |
Volume | 29,869,932 | — |
Sector | Health | Commodities - Metals/Agriculture |
52-Week High | $28.56 | $51.41 |
52-Week Low | $23.29 | $31.18 |
Enterprise Value | $192.80B | — |
Dividend Yield | 6.9% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Pfizer (PFE) trades at $24.83, up 0.32% today, with a neutral technical signal and bearish moving averages. The company reported revenue of $62.58B in 2025, with a net income margin of 11.83%, and has beaten EPS estimates for the last three quarters. Recent news highlights pipeline developments in oncology and obesity, with a consensus analyst price target of $28.25.
PFE offers a stable dividend and trades below analyst targets, but faces headwinds from patent expirations and volatile cash flows. The stock presents value with a P/E of 19.04, though growth depends on successful drug launches and navigating post-COVID revenue normalization.
SGOL is trading at $38.16, down 0.16% with bearish technical signals dominating. The stock shows 16 sell signals versus only 1 buy signal across technical indicators, with moving averages indicating strong bearish momentum. Recent gold market volatility and interest rate expectations are creating headwinds for gold-related assets. The stock lacks available fundamental data for traditional valuation metrics.
The outlook remains cautious given the bearish technical setup and gold market uncertainty. Investment opportunities exist for contrarian investors betting on gold's safe-haven appeal amid geopolitical tensions. Key risks include continued interest rate pressure, gold price volatility, and the stock's technical weakness potentially extending further.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Pfizer Inc
Pfizer Inc. operates as a pharmaceutical company. The Company offers medicines, vaccines, medical devices, and consumer healthcare products for oncology, inflammation, cardiovascular, and other therapeutic areas. Pfizer serves customers worldwide.
Read more on PFE →About ABRDN Physical Gold Shares ETF
SGOL is an ETF that is designed to track the performance of the price of gold bullion. The fund is backed by physical gold held in secured vaults, which is allocated to the ETF's custodian account. By providing direct ownership of gold without the need for physical storage or insurance, SGOL offers investors a convenient and cost-effective way to gain exposure to the gold market.
Read more on SGOL →
